Medicines for Europe Calls Out Threat Of Generics Supply Consolidation In EU Market
Off-patent drugs industry trade group Medicines for Europe has penned an open letter to the EU containing several suggestions for how the union might tackle supply chain pressures in the generics sector.
You may also be interested in...
Formycon has submitted its aflibercept candidate for European Medicines Agency consideration, following an incredibly strong Q3 which has put the company on track for a promising future.
Amphastar management has assured stakeholders that it will continue to benefit from competitor shortages for the foreseeable future, with chief financial officer Bill Peters noting that the firm has been plugging gaps in the market throughout his near-decade at the company.
Stock prices at ANI Pharmaceuticals dropped 14.8% following its Q3 results announcement, despite a guidance raise from the company, after it noted that competitor supply disruptions seemed to be easing off.